InMode Ltd. (INMD): Cost of Revenue

Annual figures by period end, from SEC filings.

$79.53M
Year ended 2025-12-31
+2.7%
3-year compound annual growth
+20.9%
5-year compound annual growth
$80.71M2017-12-31: $9.05M2018-12-31: $15.06M2019-12-31: $20.24M2020-12-31: $30.85M2021-12-31: $53.59M2022-12-31: $73.48M2023-12-31: $80.71M2024-12-31: $77.75M2025-12-31: $79.53M$79.53M
2017-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$79.53M+2.3%2026-02-10, From 2025-01-01
2024-12-31$77.75M-3.7%2026-02-10, From 2024-01-01
2023-12-31$80.71M+9.8%2026-02-10, From 2023-01-01
2022-12-31$73.48M+37.1%2025-02-04, From 2022-01-01
2021-12-31$53.59M+73.7%2024-02-13, From 2021-01-01
2020-12-31$30.85M+52.4%2023-02-14, From 2020-01-01
2019-12-31$20.24M+34.4%2022-02-10, From 2019-01-01
2018-12-31$15.06M+66.3%2021-02-10, From 2018-01-01
2017-12-31$9.05Mn/a2020-02-18, From 2017-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
InMode Ltd. (INMD)2025-12-31$79.53M+2.3%
TransMedics Group, Inc. (TMDX)2025-12-31$242.69M+35.2%
Axogen, Inc. (AXGN)2025-12-31$57.85M+27.5%
Outset Medical, Inc. (OM)2025-12-31$72.72M-3.2%
Conmed Corp (CNMD)2025-12-31$624.25M+8.8%
LivaNova PLC (LIVN)2025-12-31$448.18M+12.1%
Vaso Corp (VASO)2025-12-31$34.42M-0.8%
Ceribell, Inc. (CBLL)2025-12-31$10.79M+24.1%
Integer Holdings Corp (ITGR)2025-12-31$1.35B+7.6%

Compare INMD, TMDX, AXGN, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗